Capital scrambles to lay out, digital therapy becomes "new medical outlet"

Digital Therapeutics (DTx) is an intervention program based on evidence-based medicine driven by software programs to treat, manage or prevent diseases
.
Digital therapy can be used alone or in combination with drugs, medical devices or other therapies
.
It mainly affects patients through information (such as text, pictures, and videos on the App), physical factors (such as sound, light, current, magnetic field, and combinations thereof), drugs, etc.
, to optimize patient care and health outcomes
.
Since 2020, the wave of "digital therapy" has begun to sweep across the smart medical field, and even the pharmaceutical field, and has attracted a wide range of eyes from hospitals, R&D and investment
.
Statistics show that in 2020, there will be 692 financing incidents in the digital medical field, with a cumulative financing amount of 133.
5 billion yuan, which is second only to biomedicine
.
In 2021, digital healthcare continued to ride the wind.
In the first half of the year alone, there were 465 financing incidents, and the total disclosed financing amounted to RMB 111.
03 billion, almost reaching the global total financing amount in 2020
.
The analysis believes that capital's heavy bet on digital healthcare actually fully reflects its optimism in this field
.
According to the report "Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Forecasts 2019-2024" released by the market research organization Juniper Research, the digital therapy market will expand rapidly in the next 5 years, and the market size will exceed 32 billion U.
S.
dollars in 2024
.
In this context, the industry predicts that in the future, with the injection of funds, increased investment in scientific research, and increased public awareness, digital therapy will be able to penetrate more medical fields, and while the market continues to expand, more and more realizations will be realized.
What a new breakthrough
.
It is worth noting that the concept of "digital therapy" first appeared in the U.
S.
Food and Drug Administration (FDA).
At that time, the FDA issued emergency approval guidelines for digital therapy, which led to the beginning of the track.

.
In November 2020, after China approved the first digital therapy, domestic companies have begun to follow the international footsteps and vigorously promote the development of digital therapy
.
It is reported that in China, although digital therapy started relatively late, it has developed very rapidly.
At present, a number of digital therapy companies with outstanding performance have emerged
.
For example, Shangyi Technology, which developed the first digital therapy app in China
.
Prior to this, Shukang APP passed the approval of the National Medical Products Administration (NMPA) of China.
As a prescription, it was directly issued by doctors for patients, which also opened the prelude to China's digital therapy
.
In addition, companies that deploy digital therapy include Liuliu Brain, which focuses on the field of cognitive impairment, the first batch of domestic companies to join DTA, and Wangli Technology, a digital therapy company for mental illness
.
In general, although the current domestic digital therapy is still in its infancy, based on the rapid development of the new generation of domestic information technology and Internet medical health, as well as the huge population base, the development of digital therapy has broad prospects
.
Of course, it should be noted that in the development process of digital therapy, various subjects such as medical institutions, research institutions, technology-based enterprises, and service-oriented enterprises also need to actively explore and cooperate in order to develop more orderly and healthily
.